Previous studies have suggested that HLA-DRB1*11 may provide protection against severe forms of COVID-19 [13] and since the present study mainly included non-severe cases, it is possible that the prevalence of HLA-DRB1*11 was higher in this population. Here, HLA-DRB1 is linked to COVID-19.